Remove Chronic Pain Remove Epilepsy Remove Research and Development Remove Topical
article thumbnail

What Are The Most Common Conditions MMJ Is Prescribed For?

MMJ Recs

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. Medical marijuana, however, has emerged as a potential alternative.

article thumbnail

Is Cannabis Linked To Mental Health Issues?

PrestoDoctor

Cannabis and Mental Health Issues The association between cannabis use and mental health has long been a topic of interest. Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. Research suggests that there is indeed a link between cannabis use and mental health issues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children

Cannabis Law Report

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. Mack, Chairman and CEO of Virpax.

article thumbnail

Understanding the Endocannabinoid System: A Guide for Medical Marijuana Patients

MMJ Recs

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects.

Patients 105
article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Cannabis Law Report

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. In October 2021, Virpax announced that a $1.87

article thumbnail

Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

Cannabis Law Report

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer.